TrialBMC pulmonary medicine2026

Probiotic supplementation reduces IL-6 and improves clinical outcomes in patients with mild-to-moderate COPD: a randomized placebo-controlled trial.

Sharareh Ebrahimi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.